Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital.
暂无分享,去创建一个
I. Judson | S. Kaye | S. Stapleton | J. D. de Bono | V. Karavasilis | L. Digue | D. Eaton | T. Arkenau
[1] K I Kaitin,et al. Obstacles and Opportunities in New Drug Development , 2008, Clinical pharmacology and therapeutics.
[2] D. Camidge,et al. Dynamic and modern: bringing the ethics of phase I trials up to date. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Pond,et al. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital , 2006, BMC Cancer.
[4] Julian Downward,et al. Cancer biology: Signatures guide drug choice , 2006, Nature.
[5] P. Steeg. Cancer biology: Emissaries set up new sites , 2005, Nature.
[6] Seiichiro Yamamoto,et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. , 2005, The New England journal of medicine.
[7] C. Daugherty. Ethical issues in phase I clinical trials. , 2004, Clinical advances in hematology & oncology : H&O.
[8] J. Shaw,et al. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study , 2003, BMJ : British Medical Journal.
[9] D. Gandara,et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. Daugherty. Ethical Issues in the Development of New Agents , 2004, Investigational New Drugs.